AbClon
Seoul
About AbClon
AbClon Inc. engages in the research and development of antibody drugs in South Korea and Sweden.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $15.4M
- Last round: Convertible Note (Sep 2022)
- Website: abclon.com
- Phone: 02-2109-1294
Industries & Categories
Biotechnology, Health Care, Information Technology, Therapeutics
Canonical: https://fsome.com/organization/abclon-82001 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.